SYMPOSIUM ON SOME NEW APPROACHES TO CALCIUM METABOLISM Dr. G. Alan Rose1 (London):
The Relative Importance of the Ionized and Complexed Fractions of Calcium in Human Plasma in Control of the Urine Calcium There is frequently a remarkable lack o correlation between the plasma calcium and the urine calcium, even in the presence of what appears to be normal renal function. Thus a patient with parathyroid adenoma and elevated plasma calcium had a low urine calcium attributed to accompanying steatorrhcea (Davies et al., 1956) . Conversely normal plasma calcium is frequently present in idiopathic hypercalciuria. The normal urine calcium of approximately 120-250 mg. a day is only a very small fraction of the total plasma calcium of about 86 grams which passes through the kidneys with the blood each day. If we assume, although there is no evidence for this, that the plasma profein-bound calcium does not pass into the glomerular ultrafiltrate in significant amount, then the total calcium available for excretion is reduced to about 10 5 grams a day. This figure is still far above the observed daily urine calcium so that nearly all of the ultrafiltered calcium must be reabsorbed. Nearly all of the in vitro ultrafiltrable calcium is ionized, although a small fraction is diffusible but not ionized and includes about 0-2 mg./100 ml. of calcium complexed to citrate (Rose, 1957) . If this citrate-bound fraction alone were excreted in the urine then the daily urine calcium would be about 350 mg. This figure is so close to the observed values that we have censidered it worth while to devise experiments intended to assess the importance of plasma complexed calcium in control of urine calcium, as compared with the ionized calcium. Data available from the literature on this point are scanty. Chen and Neuman (1955) following experiments on dogs suggested that urine calcium might be dependent upon a non-ionized but ultrafiltrable complex of calcium, while the data of Freeman and Chang (1950) suggest that in dogs the plasma citrate-bound calcium may be considerably more important 'In receipt of a grant from the Medical Research Council. MAY than the plasma ionized calcium in controlling urine calcium. Data from human subjects are even more scanty.
Our experimental approach has been to infuse intravenously in approximately two minutes into normal volunteers either calcium chloride, to raise the plasma ionized calcium by about 1'5 mg./100 ml., or sodium citrate, to raise the plasma complexed calcium by about thesame amount. The exact effects of these infusions upon the plasma calcium fractions, and upon the plasma citrate, and urinary calcium and citrate have been observed and compared. The results are presented in shortened form: the detailed results are to be published elsewhere (Harper et al., 1959) . Fig. 1 chloride infusions. The rise,in plasma ionized calcium was followed by an immediate and approximately sixfold rise in the urine calcium. Such results are similar to those of the many others who have infused calcium gluconate, although comparison is difficult in view of the differing time scales. Fig. 2 shows the results of the sodium citrate infusions. Despite a fall in the plasma ionized calcium which might have been expected to result in a fall in urine calcium, an immediate sixfold increase in urinary calcium was observed. It is deduced that this calcium diuresis was due to elevation of the plasma complexed calcium. The calcium diuresis of citrate infusion was poorly sustained because of the rapid rate of fall of plasma citrate after the infusion, this presumably being due mainly to metabolism of citrate rather than to urinary excretion.
Sodium isocitrate was also infused into one individual in order to see whether citrate was specific in its ability to induce calcium diuresis. The results ( Fig. 3) showed that a comparable dose of isocitrate caused a smaller rise in plasma complexed calcium than did the citrate (since the formation constant of calcium isocitrate is less than that of calcium citrate) but that this rise was apparently better sustained than the rise after citrate infusion. Following this infusion the rise in urine calcium was the largest which we observed in our series, and it was better sustained than the calcium diuresis which followed citrate infusion. We have therefore deduced that the calcium isocitrate complex had a higher renal clearance than the calcium citrate complex, and indeed it appears likely that the calcium isocitrate complex was being excreted at the rate of glomerular ultrafiltration.
Calcium gluconate infusions lead to sodium diuresis (Freedman et al., 1958) , so that it was thought necessary to give a control sodium chloride infusion and observe the effect of this upon urine calcium. No significant rise in urine calcium was observed. Following citrate infusion, the urine was tested for reducing substances, and for amino acids by paper chromatography, and no increases were noted.
The clinical implications of these observations are considerable. It is clear from our results that a large rise in urine calcium may be due to a small rise in either the ionized or complexed fractions of calcium in the plasma. Although the point is not completely proven it seems likely from our data that under normal conditions these fractions contribute to the urine calcium in approximately equal proportions. In any case, however, it may be inferred that a rise of 50 % in urine calcium may be due to a rise in plasma 348 complexed calcium of only 0-3 mg./100 ml. Such a rise would hardly be considered significant if only the total plasma calcium were to be measured, and the latter value would indeed probably be within normal limits. Perhaps it is hardly surprising therefore that there is sometimes little correlation between plasma calcium (total) and urine calcium. In vitamin-D therapy the urine calcium may rise before there is any change in plasma (total) calcium. This is now readily explained when it is recalled that vitamin D raises the plasma citrate (Harrison and Harrison, 1952) . It is possible that some cases of "idiopathic" hypercalciuria might be due to disturbance of citrate metabolism and that this substance might then be raised in the plasma leading to "overflow" of calcium citrate complex into the urine. Alternatively, there might be a failure of the renal tubules to reabsorb the calcium citrate complex other things being normal. Other cases, however, of "idiopathic" hypercalciuria might be due to similar disturbances in metabolism of isocitrate. We would suggest that other organic acids known to occur in plasma should also be tested to see if they can induce calcium diuresis, and that examination of plasma organic acids provides another test which should be carried out before a hypercalciuria can truly be labelled "idiopathic". 
Dr. Lyal Watson' (London):
Citrate Metabolism in Hyperparathyroidism Since Dickens (1941) demonstrated that bone mineral is rich in citrate, which comprises about 1 % of normal bone, there has been increasing interest in the role of citrate in bone physiology and in the interrelationships of calcium and citrate metabolism generally. Dixon and Perkins (1952) showed the presence in bone of citrogenase and aconitase, enzymes necessary for citrate synthesis, and suggested that the citrate found in bone mineral might be produced locally by bone cells. Neuman and Neuman (1958) elaborated this point and proceeded further to speculate that much of the plasma citrate might also be derived from bone and to develop an interesting concept of skeletal dynamics which attributes vital roles to citric acid and the parathyroids.
These workers have shown that the circulating fluids are normally supersaturated with calcium and phosphorus in relation to the bone mineral, so that the purely physico-chemical tendency is for mineral deposition. Since bones do not progressively fossilize, there must be an active physiological mechanism to ensure bone mineral dissolution and to maintain the dynamic equilibrium of bone deposition and resorption.
Citric acid may play a vital role in this process. It is an admirable substance for the purpose, for, among other desirable properties, it forms with calcium a chelate, a highly associated compound in which calcium is soluble but unionized and may therefore be transported from bone to blood stream against an ionic gradient. This calcium can then be made available in the ionized form by the simple device of utilizing the citrate in the tissues.
Neuman and Neuman consider that the whole process is regulated by the secretions of the parathyroid glands: Neuman et al. (1956) performed an experiment in which they were able to sample blood directly from the spongiosal circulation of the femur of an intact dog and to demonstrate a dramatic increase in citrate output from the bone almost immediately after the injection of a parathyroid extract. They summarized their conclusions as follows: "A parathyroidcontrolled citrate gradient maintains a steady but supersaturated level of ionized calcium in serum Much other evidence is available to indicate a parathyroid influence on citrate metabolism. Harrison (1956) reported low plasma citrate levels in hypoparathyroidism, and Shorr et al. (1942) an increase in urinary citrate following the administration of parathyroid hormone to a hypoparathyroid subject. Dickens (1941) produced an increase of 27% in bone citrate by prolonged administration of parathyroid hormone to a pup. Alwall (1944) , L'Heureux and Roth (1953) , and Elliott and Freeman (1956b) all showed that the administration of parathyroid extracts would raise the plasma citrate level in experimental animals. Elliott and Freeman (1956a) also demonstrated that the transient elevation of plasma citrate which follows nephrectomy in certain species depends upon the integrity of the thyroid-parathyroid apparatus. The plasma citrate level did not rise following nephrectomy in parathyroidectomized rats but the response was restored to the preparation by the administration of parathyroid extracts. Finally, high blood citrate levels were found in hyperparathyroidism with bone disease by Sjostrom (1937) , Herbert (1949) and Harrison (1954) . These authors did not comment on the plasma citrate findings in hyperparathyroidism without bone disease. Shorr et al. (1948) also reported high plasma citrate levels in cases of hyperparathyroidism without specifically stating which type of disease they were investigating.
Mater-ial, Methods and Reslults
Plasma citrate levels were determined in 12 patients with hyperparathyroidism proven by the removal of a parathyroid adenoma at operation. The blood urea and the serum alkaline phosphatase were normal in all cases, nor was there any radiological evidence of hyperparathyroid bone disease. Unfortunately no suitable case of hyperparathyroidism with bone disease was available during this study.
All the blood samples were collected from patients in the fasting state. The plasma citrate was determined by the method of Ettinger et al. (1952) . Twenty-eight determinations on 19 normal individuals gave a range of 21 -3 6 mg./100 ml. by this method.
The pre-operative plasma citrate levels in the 12 patients with hyperparathyroidism without bone disease are shown in the left-hand column of Fig. ] . The values were within the normal range in 9 of the 12 cases and in only 1 case was there any pronounced elevation of the plasma citrate. Although there appeared to be a slight rise of the plasma citrate levels in comparison with normals,
the mean of the group was 3 2 mg.1100 ml. compared with a mean of 2 8 mg./100 ml. in the control group, a difference not statistically significant.
Discussion. This finding of a normal plasma citrate level in most cases of hyperparathyroidism without bone disease is in contrast with the reported findings in cases of hyperparathyroid bone disease and after administration of parathyroid extracts in experimental animals. The most likely reason for this is that we are dealing with different case material. Other differences between cases of hyperparathyroidism with and without bone disease are well recognized and these data appear to establish another point of difference.
It is of interest to consider the occurrence of normal plasma citrate levels in hyperparathyroidism in connexion with the concept of a parathyroid controlled release of citrate from bones. Blood levels alone do not disprove an osseous action since citrate occupies a central position in metabolism so that great changes in citrate turnover could occur without significant alteration in blood levels, if increased production were balanced by increased utilization.
There is increasing acceptance of the idea of a dual action of parathyroid secretions (Dent, 1953) and some speculation that the glands may actually produce different hormones with different actions (Davies and Gordon, 1953a, b) . If this is true, it could well explain the differences between cases of hyperparathyroidism with and without bone disease and these data provide another piece of evidence which may favour such a theory. It is easy to imagine different parathyroid adenomas producing different hormonal secretions and the patients under consideration may have been producing little, if any, excess of the bone-regulating hormone. 
Post-operative Studies
The study of post-operative plasma citrate levels in these patients brought to light another interesting facet of citrate metabolism. In 8 of the 12 patients the plasma citrate was determined about one week after removal of the adenoma. These values are shown in the right-hand column of Fig. 1 . In every case the plasma citrate level fell after operation. This might have been explicable as post-operative hypoparathyroidism.
As controls, 6 other patients were selected having routine operations of election. Blood was taken immediately before operation and seven days post-operatively in each case, and the plasma citrate levels (Fig. 2) showed the same response as in the parathyroid group.
Discussion.-It appears that low plasma citrate levels post-operatively are a non-specific response to the trauma and stress of operation and aniesthesia. Metabolic responses to surgery are, of course, well known but little attention has been paid to these changes in plasma citrate in articles published in the English language. Nevertheless post-operative low plasma citrate levels were described by the Scandinavians many years ago. Working in a surgical clinic, Sj6strom (1937) found them after operations of many different kinds.
This response may be due to the outpouring of adrenal corticoids known to occur after surgery. It was shown by Pincus et al. (1951) in the rabbit, by Harrison et al. (1958) in the rat and by Henneman and Henneman (1958) in man that increased serum concentrations of 17-hydroxycorticoids produced a marked fall in plasma citrate levels. Henneman and Henneman also observed a low urinary citrate in four patients after either laparotomy or open reduction of fractures and thought that the response in these cases was due to a stress reaction with adrenal cortical overactivity. It seems probable that the low plasma citrate levels seen in all these patients were due to the same mechanism.
Summary and Conclusions
(I) Most patients with hyperparathyroidism without bone disease have normal plasma citrate levels. This is quite different from the high plasma citrate levels reported in cases of hyperparathyroidism with bone disease and appears to provide another point of difference between the two clinical groups. A possible explanation of these differences has been advanced.
(2) Low plasma citrate levels occur nonspecifically after many surgical operations, and may be due to the excessive production of adrenal cortical steroids which is known to occur in response to surgery. Investigation of Bone Metabolism with 47Caa Preliminary Report There are certain aspects of mineral metabolism in relation to bone which cannot be investigated by conventional techniques. This applies in particular to the study of the absolute rates of new bone formation and bone destruction, as opposed to the net difference between formation and destruction which can be determined by a balance. It is believed that a certain amount of new bone is formed every day and that in normal subjects an equivalent amount is destroyed, but the actual magnitude can only be measured by the use of a labelled substance which enables one to distinguish between the calcium which is going into, and that which is coming out of, the skeleton. A knowledge of the rate of these processes would be of great value in the elucidation of pathological processes, and is especially relevant to the pathogenesis of osteoporosis which is widely believed to be due to a reduction in the rate of formation of new bone, the process of resorption going on at the normal rate. While it is true that osteoporosis must be due to an imbalance between the rates of accretion (i.e. new bone formation) and resorption (i.e. bone destruction) there is no conclusive evidence as to which of these processes is disturbed in osteoporosis; but it is quite possible that the conventional explanation is incorrect and that the condition is due to increased resorption rather than reduced accretion.
Until quite recently, the only radioactive isotope of calcium available was 45Ca, a betaemitter with a long half-life which is unsuitable for use in human subjects, although it has been extensively used in human studies in the U.S.A. (Bronner et al., 1956) and Sweden (Bauer et al., 1955) . However, the Atomic Energy Research Establishment at Harwell have now consented to manufacture small amounts of 47Ca, an isotope with properties which make it very suitable for metabolic studies in humans, as can be seen in Table I . Owing to its relatively high cost, irregular manufacture and short half-life the number of subjects we have studied with the isotope so far is very small, but the methods used and the results obtained may none the less be of interest.
The method of measuring bone accretion with isotopic calcium was devised by Bauer et al. (1955) and has been modified by Fraser (1957) in a strontium test. It depends upon the assumption that an injected isotope of calcium mixes with a definite quantity of exchangeable calcium in the tissue fluids and on the surface of the skeleton, and that the loss of activity from this exchangeable pool only takes place into the fiEces, the urine and into new bone as it is formed (Fig. 1) . Since the total loss of activity into the feces and urine can be measured, and the total loss from the pool can be calculated from the loss of specific activity in the body fluids, it is possible to calculate the amount of activity, and therefore the amount of calcium, going into the skeleton each day.
The subjects are given an intravenous injection of 10 microcuries of 4'Ca and the urine is collected in twenty-four-hour aliquots for seven days. The fices are also collected daily for seven days starting one day after the injection. The total activity of urine and faces is measured each day, as well as the amount of stable calcium excreted in the urine. The specific activity of the urine (percentage of dose per mg. calcium) is assumed to be the same as that of the extracellular fluid, and it is plotted on semilogarithmic paper against time as shown in Fig. 2 . The line of best fit is calculated for these 7 observations and is extrapolated back to zero time, at which point the specific activity represents that which would have been observed had there been instant mixing. The percentage of the dose per mg. of calcium at zero time is then converted into the "exchangeable calcium" by dividing it into 100. From the fall in specific activity, a constant fraction of which is lost each day, one can calculate the absolute amount of labelled calcium leaving the exchangeable pool. The average amount of calcium lost each day in the urine is then deducted from this figure, as is the amount calculated to have been lost in the fxces. (In calculating the endogenous feecal calcium, the fical activity is converted into mg. of calcium on the basis of the specific activity of the urine of the previous day to allow for the time taken for matter to pass through the gut.) The total urinary and endogenous fvcal loss is then -deducted from the total loss from the exchangeable pool to give the amount of calcium that has gone into bone by accretion. The procedure rests upon a number of assumptions of varying validity which it is not possible to discuss in this context. We are not entirely convinced that accretion is the only process measured by this calculation but it is the nearest approach to accretion which it is possible to measure at the present time.
Results
The results obtained in 7 normal subjects are shown in Table IT . It will be seen that the ex- It is evident that there is considerable variation within the two groups of 7 subjects, but there is certainly no suggestion whatever of a reduced rate of new bone formation in the patients with osteoporosis: if anything, it appears rather that their rate of bone formation is increased. Whedon and his colleagues (Heaney and Whedon, 1958) have recently reported results obtained with 45Ca in 4 patients with osteoporosis and have also found that the accretion fell within their normal range. Thus these results, and those of Whedon, do not support the concept that osteoporosis is due to a reduction in the rate of new bone formation, but are rather compatible with the idea that the loss of bone in this condition is due to increased resorption. This is not the place to discuss the possible cause of this increased resorption, except to repeat what I have suggested elsewhere-that osteoporosis is perhaps the result rather than the cause of negative calcium balance (Nordin, 1958a) . Such negative calcium balance could be due to inadequate intake, malabsorption or excessive urinary or fxcal excretion of calcium. Data in support of this view are being reported elsewhere (Nordin, 1958b) .
